Efficacy Safety of Once Weekly Semaglutide Verses Once Daily Sitagliptin as an Add as to Metformin, Thiafolinediones, or both in Patients with Type 2 Diabetes (SUSTAIN 2) : a 56 Week, Double Blind Phase 3 a Randomized Trial - Amrita Vishwa Vidyapeetham

Efficacy Safety of Once Weekly Semaglutide Verses Once Daily Sitagliptin as an Add as to Metformin, Thiafolinediones, or both in Patients with Type 2 Diabetes (SUSTAIN 2) : a 56 Week, Double Blind Phase 3 a Randomized Trial

Year : 2017

Abstract :

Admissions Apply Now